Crowdfunding
Two innovative SMEs raised more than €500,000 each with equity crowdfunding in June
Mazzanti, a manufacturer of high-performance cars, and Ez-Lab, a company specialized in blockchain in the agri-food industry, raised (€611,000) and (€728,000) on Crowdfundme and Mamacrowd respectively. Mazzanti will invest the funds in the ongoing development of new car models and the continuous limited edition production of up to 25 of each model.
If despite the crisis, real estate crowdfunding has not slowed down its run in Italy, equity crowdfunding is showing signs of a strong recovery. In particular, two campaigns have abundantly exceeded the psychological threshold of half a million euros in funding.
They are two innovative SMEs: Mazzanti Automobili, which collected $685,000 (€611,000) on CrowdFundMe and Ez Lab, which collected $816,000 (€728,000) on Mamacrowd.
Find out more details about the most recent successful crowdfunding campaigns on Mamacrowd and CrowdFundMe with the Born2Invest mobile app. Read the most important financial news in the world and be the first to know the latest updates in the financial market.
Mazzanti Automobili will use the money raised to develop new car models
Mazzanti Automobili is a manufacturer of very high performance racing and collector cars 100% made in Italy. After more than 20 years of research and development, prototypes and exclusive “one-off” unique pieces sold, on order, in different countries around the world, the company has just started the continuous production of a limited number of models of the Evantra Millecavalli model. That is a hypercar already known and appreciated among the passionate collectors, technicians, drivers and among the major influencers of the automotive world.
At the helm of the company is Luca Mazzanti, an entrepreneur with consolidated experience in the automotive sector, including that of restorer of historic and racing cars.
The minimum target of the campaign on CrowdFundMe was $336,000 (€300,000), which more than doubled the actual collection, thanks to more than 180 investors and a pre-money valuation of $4.49 million (€4 million).
The funds will be invested in the ongoing development of new car models and the continuous limited edition production of up to 25 of each model.
Ez Lab raised three times more than the minimum target
EZ Lab specializes in advanced digital solutions for the food industry. It was one of the first companies in the world to have realized, in 2016, the first case in the world of traceability in the wine supply chain, from field to bottle, creating a blockchain register for the wine of Cantina Volpone.
Since 2014, year of foundation at the university incubator Galileo Visionary District, EZ Lab has carried out about 40 blockchain traceability projects in the agri-food and Made in Italy products. It is also involved in the ministerial experimentation of blockchain applied to 5G technology, thanks to a project with Wind/3. Finally, it is a business partner of IBM food trust, IBM’s blockchain platform for the retail sector.
In 2016, its AgriOpenData platform was awarded at SMAU as the best technological innovation for the traceability of agricultural products. In 2017, EZ Lab was the only Italian company selected by the Thrive incubator in California, specializing in the food tech sector.
The round on Mamacrowd raised about $819,000 (€730,000), against a minimum target of $224,000 (€200,000) thanks to 340 investors, with a pre-money valuation of $3.9 million (€3.5 million).
The funds raised will be used for the consolidation of the positioning already achieved in the agrifood sector, and for the launch of joint ventures and partnerships with Key Players in new sectors such as energy, supply-chain, logistics, legaltech, Insurtech, smart cities, manufacturing, art and anti-counterfeiting.
__
(Featured image by LeeRosario via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Rovi Cuts Its Profit by 4% in the First Nine Months, to 113.5 Million
-
Biotech3 days ago
Better Care Advances Healthcare Technology with Partnership with Oracle
-
Fintech1 week ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech22 hours ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant